Sponsor Pipeline

Shanghai Lanyi Therapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07256301 A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal… PNH - Paroxysmal Nocturnal Hemoglobinuria Recruiting
NCT07632976 A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With… Antiphospholipid Syndrome (APS) Active, Not Recruiting
Get alerts when Shanghai Lanyi Therapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free